This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

OSCAR J. SOKOLOFF, M.D.

AMA Arch Derm. 1956;74(4):393-396.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Recently published studies^* of a new tranquilizing drug called meprobamate (Miltown) reported very encouraging results with psychiatric patients, particularly with those suffering from anxiety and tension states. The drug (chemically 2-methyl-2-n-propyl-1,3-propanediol dicarbamate) was reported to possess muscle-relaxant properties similar to those of mephenesin but of much longer duration, as well as unusual tranquilizing properties apparently related to a specific effect on the activity of the thalamus. All investigators described the drug as extremely low in toxicity and devoid of important side-effects.

Because certain dermatological syndromes have so frequently appeared closely bound up with emotional factors, the use of sedatives as an adjunct to therapy has become widespread in these conditions. Until recent years the barbiturates were most commonly used. Their usefulness, however, was limited by the fact that they dulled the sensorium and entailed the possibility of addiction. More recently . . . [Full Text PDF of this Article]

Author Affiliations
New Brunswick, N. J.

The Miltown for this study was supplied by Wallace Laboratories, Inc., New Brunswick, N. J.

Footnotes
Submitted for publication Dec. 5, 1955.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter     What's this?